Postshunt encephalopathy in liver transplanted children with portal vein thrombosis

P Tissières1, D Pariente, C Chardot

  • 1Groupe de Transplantation Hépatique Pédiatrique, Assistance Publique, H pitaux de Paris, France.

Transplantation
|December 16, 2000
PubMed

Insights

Portosystemic shunting can cause acute encephalopathy in liver transplant recipients with portal vein thrombosis. This complication can be fatal, necessitating alternative treatments to restore liver graft blood flow.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Pediatric Gastroenterology

Background:

  • Portal hypertension in liver transplant recipients with portal vein thrombosis (PVT) is often managed with surgical portosystemic shunting.
  • PVT is a significant complication following liver transplantation, impacting graft function and patient outcomes.

Observation:

  • Two pediatric liver transplant recipients with PVT developed acute encephalopathy after portosystemic shunt creation or preservation.
  • One patient underwent a mesocaval H-type shunt, while the other had a spontaneous splenorenal shunt preserved.

Findings:

  • Post-shunt encephalopathy occurred months to years after transplantation in both cases.
  • One child succumbed to the complications of encephalopathy, highlighting a dismal outcome.

Implications:

  • Portosystemic shunting carries a risk of severe neurological complications, including fatal encephalopathy, in pediatric liver transplant recipients with PVT.
  • Alternative strategies that restore hepatopetal blood flow to the liver graft are crucial for managing PVT in this vulnerable population.
Abstract

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...